These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24817342)

  • 1. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance: response.
    Cara-Fuentes G; Johnson RJ; Reiser J; Garin EH
    Pediatr Nephrol; 2014 Aug; 29(8):1467-8. PubMed ID: 24817342
    [No Abstract]   [Full Text] [Related]  

  • 2. CD80 and suPAR: diagnostic and pathogenic value in minimal change disease and focal segmental glomerulosclerosis?
    Davin JC
    Pediatr Nephrol; 2014 Aug; 29(8):1465-6. PubMed ID: 24839215
    [No Abstract]   [Full Text] [Related]  

  • 3. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.
    Cara-Fuentes G; Wei C; Segarra A; Ishimoto T; Rivard C; Johnson RJ; Reiser J; Garin EH
    Pediatr Nephrol; 2014 Aug; 29(8):1363-71. PubMed ID: 24263531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease.
    Ahmed HM; Ezzat DA; Doudar NA; Adel M
    Iran J Kidney Dis; 2018 Mar; 12(2):107-111. PubMed ID: 29507273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of urinary CD80 as a diagnostic marker in patients with renal diseases.
    Minamikawa S; Nozu K; Maeta S; Yamamura T; Nakanishi K; Fujimura J; Horinouchi T; Nagano C; Sakakibara N; Nagase H; Shima H; Noda K; Ninchoji T; Kaito H; Iijima K
    Sci Rep; 2018 Nov; 8(1):17322. PubMed ID: 30470792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular endothelial cells and podocytes can express CD80 in patients with minimal change disease during relapse.
    Cara-Fuentes G; Venkatareddy M; Verma R; Segarra A; Cleuren AC; Martínez-Ramos A; Johnson RJ; Garg P
    Pediatr Nephrol; 2020 Oct; 35(10):1887-1896. PubMed ID: 32399663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome.
    Mishra OP; Kumar R; Narayan G; Srivastava P; Abhinay A; Prasad R; Singh A; Batra VV
    Pediatr Nephrol; 2017 Aug; 32(8):1355-1361. PubMed ID: 28210837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease.
    Spinale JM; Mariani LH; Kapoor S; Zhang J; Weyant R; Song PX; Wong HN; Troost JP; Gadegbeku CA; Gipson DS; Kretzler M; Nihalani D; Holzman LB;
    Kidney Int; 2015 Mar; 87(3):564-74. PubMed ID: 25354239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary CD80 excretion is a predictor of good outcome in children with primary nephrotic syndrome.
    Ling C; Liu X; Shen Y; Chen Z; Fan J; Jiang Y; Meng Q
    Pediatr Nephrol; 2018 Jul; 33(7):1183-1187. PubMed ID: 29569191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD80, suPAR and nephrotic syndrome in a case of NPHS2 mutation.
    Cara-Fuentes G; Araya C; Wei C; Rivard C; Ishimoto T; Reiser J; Johnson RJ; Garin EH
    Nefrologia; 2013; 33(5):727-31. PubMed ID: 24089165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with primary focal segmental glomerulosclerosis with detectable urinary CD80 are more similar to patients with minimal change disease in clinicopathological features.
    Gong X; Huang J; Zhang Y; Wang F; Wang X; Meng L; Cheng X; Liu G; Cui Z; Zhao M
    Ren Fail; 2023; 45(2):2279642. PubMed ID: 37942512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS.
    Li F; Zheng C; Zhong Y; Zeng C; Xu F; Yin R; Jiang Q; Zhou M; Liu Z
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1903-11. PubMed ID: 25318750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary myo-inositol is associated with the clinical outcome in focal segmental glomerulosclerosis.
    An JN; Hyeon JS; Jung Y; Choi YW; Kim JH; Yang SH; Oh S; Kwon S; Lee SH; Cho JH; Park SH; Ha H; Kim DK; Lee JP; Hwang GS
    Sci Rep; 2019 Oct; 9(1):14707. PubMed ID: 31605028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CD80: cluster of differentiation or clinically different?].
    Torreggiani M
    G Ital Nefrol; 2011; 28(1):14. PubMed ID: 21341240
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.
    Garin EH; Mu W; Arthur JM; Rivard CJ; Araya CE; Shimada M; Johnson RJ
    Kidney Int; 2010 Aug; 78(3):296-302. PubMed ID: 20485332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis.
    Huang J; Liu G; Zhang YM; Cui Z; Wang F; Liu XJ; Chu R; Zhao MH
    BMC Med; 2014 May; 12():81. PubMed ID: 24884842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary CD80 levels as a diagnostic biomarker of minimal change disease.
    Ling C; Liu X; Shen Y; Chen Z; Fan J; Jiang Y; Meng Q
    Pediatr Nephrol; 2015 Feb; 30(2):309-16. PubMed ID: 25142334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximal 'CD80-uria' with minimal change.
    Kistler AD; Reiser J
    Kidney Int; 2010 Aug; 78(3):236-8. PubMed ID: 20631735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Messenger RNA expression of B7-1 and NPHS1 in urinary sediment could be useful to differentiate between minimal-change disease and focal segmental glomerulosclerosis in adult patients.
    Navarro-Muñoz M; Ibernon M; Pérez V; Ara J; Espinal A; López D; Bonet J; Romero R
    Nephrol Dial Transplant; 2011 Dec; 26(12):3914-23. PubMed ID: 21414970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis.
    Garin EH; Reiser J; Cara-Fuentes G; Wei C; Matar D; Wang H; Alachkar N; Johnson RJ
    Pediatr Nephrol; 2015 Mar; 30(3):469-77. PubMed ID: 25239302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.